Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma
Clinical trial NCT02272686 · TERMINATED
Trial details
- NCT number
- NCT02272686
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-03
- Primary completion
- 2017-12-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.